entertainment -WSS

entertainment

author：comprehensive 2025-08-26 23:47:06 - browse：5

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday.

Amyloid PET scans are important tools to help determine whether patients with mild cognitive impairment are good candidates for new Alzheimer’s drugs, including Eisai and Biogen’s drug Leqembi, which means there will likely be an increase in demand for the scans as uptake increases.

Previously, Medicare limited coverage for the drug to patients enrolled in clinical studies, and only covered one scan in a patient’s lifetime. The new coverage policy removes those restrictions and delegates decisions about how many scans to cover to regional Medicare administrators.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Prime Medicine, Myeloid Therapeutics clash over genome

WSS

SNAP should offer more nutrition education

Violet CEO on training clinicians to promote more inclusive care

HCA sued by state AG for quality issues at Mission Health

STAT Summit: Ending the crisis of Black deaths in the U.S.

Editas, Vertex strike deal on CRISPR

Smaller biotechs seek to piggyback on weight loss drug boom

Wikipedia

entertainment

knowledge

Affirmative action in medical school literally saved lives

Christmas in the PICU brings some surprising joy

Alkermes shareholders re

STAT Summit: Meghan O’Rourke on making chronic illness visible

After affirmative action ruling, medical educators look to 'holistic review'

Hospitals owned by private equity see complications spike 25%

Wildfire smoke exposes gaps in outdoor worker protections

STAT Summit: Ending the crisis of Black deaths in the U.S.

Medical records are filled with copy

Results on Novartis prostate cancer therapy could expand its use

knowledge

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Drinking less cuts risk of oral cavity, esophageal cancer: Report

SNAP should offer more nutrition education

Roivant's CEO is a star, but biotech's black hole persists

Health tech investors get more selective as pandemic boom fades

Smaller biotechs seek to piggyback on weight loss drug boom

explore

leisure time

knowledge

focus